The major factors driving
the growth of Pharmaceutical Membrane
Filtration Market are the increasing adoption of single-use
technologies and the growing demand for nanofiltration.
The global Pharmaceutical membrane filtration market is expected to grow from USD 5.8 billion in 2020 to USD 10.2 billion by 2025, at a CAGR of 12.0% from 2020 to 2025.
The major players operating
in the pharmaceutical membrane filtration market include Merck (Germany),
Danaher (US) and Sartorius Stedim Biotech (France). These players have adopted
various growth strategies, such as product launches, partnerships &
collaborations, and expansions to increase their presence in the global market.
Merck Millipore (Germany) is the leader in the global pharmaceutical
membrane filtration market. The company prominently focuses on organic growth
strategies such as product launches and acquisitions to strengthen its market
position in the pharmaceutical membrane filtration market. Merck offers a wide
range of innovative products in the pharmaceutical and biopharmaceutical
industry. The company’s membrane filters are used for the separation and
purification of APIs, biological samples, and buffers to obtain the highest
quality results from downstream analysis. Merck’s wide range of membranes,
filter holders, and related filtration devices are used to collect,
separate, or remove contaminants from air or fluid samples prior to downstream
analysis.
Get Data as per your Format and
Definition | REQUEST FOR CUSTOMIZATION:-
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=255408031
Danaher (US) is the second-largest player in the global
pharmaceutical membrane filtration market. Pall Corporation, a subsidiary of
Danaher, is involved in offering pharmaceutical filtration products. The
company is a global leader in high-tech filtration, separation, and
purification, serving the diverse needs of customers across the broad spectrum
of the life sciences industry. The company offers a comprehensive portfolio of
advanced filters that are used in the pharmaceutical and biopharmaceutical
industry.